Technology: Introducing OxyFusion™

OxyFusion™ is the new cost-effective Theranostics medium innovation that will expand the reach of hospitals and clinics using the existing MRI equipment to perform metabolic imaging. It works with current MRI equipment eliminating need for new Capex and setup of new hot labs as well as the training of specialized personnel.

Current metabolic imaging is restricted to hospitals with hot labs facilities using radioactive agents that are hazardous, inefficient and restrictive in their ability to be re-applied in short intervals.  There is a critical and un met clinicl need for timely real-time HD imaging of cellular metabolic function to detect stroke, heart attack and in neoplasm’s management for providing accurate treatment.

OxyFusion’s™ unique FDA approved PFD, stabilized emulsion oxygenated with our proprietary patented Oxy-17®, enables the revival of dying cells and accurate real-time monitoring.  OxyFusion™ provides an in vivo Oxygen bridge once the diagnostic MRI imaging is completed and the lungs work to deliver enriched Oxygen to hypoxic or ischemic tissue. Study has shown a 50% reduction in infarcts size when perfused with the emulsion compared to saline and hyperoxemia.  OxyFusion small molecular size penetrates to oxygenate, and revive dying cells in areas affected by blood clots.

Why settle for the old way of doing things?  At Rockland Technimed, that’s the question we asked ourselves – and the answer was OxyFusion.
OxyFusion™ is the only non-radioactive MRI metabolic imaging agent available on the market today.  It replaces current imaging methods that employ the use of potentially dangerous radioactive agents, which also eliminates the need for expensive cyclotron and hot laboratory setup.  It effectively provides critical metabolic information using conventional, readily available MRI equipment – which greatly increases access, lowers costs and the need for specially-trained personnel.

Additionally, OxyFusion™  is the only product that solves this problem and provides the impressive additional benefit of delivering oxygen to oxygen-starved tissue.  This fact places us squarely within the growing field of theranostics, or personalized, therapy-based diagnostics.  With the built-in ability to use OxyFusion with any existing MRI equipment, markets are opened up both domestically and globally – giving us the potential to act as a true market leader.

Theranostics

The process we use is rather simple.  The OxyFusion™ emulsion, which is basically pre-dissolved Oxygen-17, is injected into the target area.  Instead of radioactive elements, it utilizes oxygen – one of the most readily available elements on our planet – to impact the targeted tissue and make it detectable to an MRI

This is where the dual-pronged diagnostic/therapeutic benefits come into play.  Oxy-17® then bypasses blockage and gets delivered directly to the oxygen-starved tissue, providing much-needed relief to cells suffering from hypoxia.  By observing this process, physicians can then calculate the rate at which the oxygen is being consumed and eventually deliver a successful diagnosis.

OxyFusion's Uses

With this process, not only is the targeted tissue getting a valuable infusion of oxygen, but the diagnostic process also gets underway.  The oxygen helps to display the cells’ metabolic processes, which can then be viewed using standard MRI equipment.  Some of OxyFusion’s more common uses include:

OxyFusionUses

Patient Benefits

 


ABOUT US
Overview
Management Team
Board of Directors
Scientific Advisory Board


TECHNOLOGY
Introducing OxyFusion®
Theranostics
OxyFusion® Uses
Patient Benefits


PRODUCTS
Oxy Fusion
Oxy Gas
Oxy Water


MEDIA CENTER
Overview
News

Press Releases
Publications & Abstracts


CONTACT US